NIH says its Unified Funding Strategy took effect with the January 2026 advisory-council round and applies across the agency’s institutes, centers and offices. The virtual briefing was intended to explain the strategy’s rationale, implementation and common misconceptions. NIH says a recording and related resources will be posted seven to 10 business days after the event.

What changed for applicants

Under the framework, NIH institutes and centers are directed to consider the full peer-review record rather than rely mainly on an overall impact score or a fixed cutoff. That includes reviewers’ scores, written critiques and the broader scientific information produced through review.

NIH says institutes, centers and offices will not rely on paylines or fixed overall-impact-score cutoffs when developing pay plans under the unified approach. Some institutes previously used paylines based partly on scores or percentiles. Those systems gave applicants a rough benchmark, although NIH’s own explanation notes that applications inside a payline were not always funded and applications outside one could sometimes be funded.

The new framework does not eliminate peer review. NIH describes peer review as a required, independent and expert part of the process. Applications continue through two levels of review, and advisory councils continue to provide recommendations before final funding decisions are made.

Who makes the final decision

Program staff help develop funding plans, and advisory councils conduct the second level of review and provide guidance. Institute and center directors retain delegated authority to decide which awards their organizations fund.

Directors may consider the actual budget needed for a grant, opportunity costs, existing funding commitments and stewardship of taxpayer investments. NIH says directors are not required to rely solely on the budget requested by an applicant or the budget evaluated during peer review.

The broader factors NIH lists

NIH’s published framework identifies six central considerations:

• Alignment with the NIH mission
• Scientific merit, with peer-review information considered in its entirety
• Breadth of topics and approaches, including program balance
• Investigator career stage and sustainability of the biomedical research workforce
• Broad distribution and geographic balance of funding
• Availability of institute or center funds

In practical terms, two applications with similar review outcomes could receive different decisions if they address different mission priorities, fill different gaps in an institute’s research portfolio or face different budget conditions. That is not a promise that one type of applicant or one location will receive favorable treatment. It reflects NIH’s position that each institute may apply the common principles within its own mission, portfolio and available resources.

Why accountability matters more

More discretion can allow NIH leaders to respond to emerging scientific opportunities and maintain a broader research portfolio. It also makes funding outcomes harder to forecast from scores alone. That can complicate budget planning for universities, research hospitals and laboratories that depend on federal grants for staffing and long-term projects.

The accountability question is whether applicants and the public will receive enough consistent information to understand how the discretion is used. NIH has said the strategy is intended to support clearer and more consistent decisions, and its materials point researchers toward institute-level funding policies, strategic priorities and centralized information.

Researchers should watch those institute policies, advisory-council materials, award timelines and any explanations NIH provides about decision factors. Success-rate data can offer broader context, but NIH defines success rates as awards divided by applications received in a fiscal year, with resubmissions counted once. They are program-level measures, not individual funding odds.

Independent reporting by Nature has separately described delays and additional screening affecting some NIH grants. Those reports concern attributed allegations about post-review administrative scrutiny and should not be treated as proof that the Unified Funding Strategy itself changes peer-review standards. NIH’s published policy says peer review remains central while mission, portfolio and budget factors are considered alongside it.

For applicants, the immediate lesson is that a high score remains important but may no longer provide a predictable funding threshold. The relevant institute’s current funding policy and priorities now deserve the same attention as any historical payline.

Sources

• NIH event page: Understanding NIH’s Unified Funding Strategy
• NIH Extramural Nexus: Implementing a Unified NIH Funding Strategy
• Nature: Inside the new political screening that’s stalling NIH grants